Chapter 35: Management of Anxiety Disorders

Pharmacology for Nursing Care, 7th Edition by Richard A. Lehne

$2.99

Chapter 35: Management of Anxiety Disorders

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

  1. A patient is brought to the emergency department in a state of extreme uncontrolled anxiety. The prescriber orders a benzodiazepine. A nurse understands that benzodiazepines are used in this clinical situation based on which of the following principles?
a. Benzodiazepines have a very short half-life.
b. There is no risk of physical dependence when taking benzodiazepines.
c. Benzodiazepines are known to cure generalized anxiety.
d. Benzodiazepines have a rapid onset of action.

 

 

ANS:   D

The patient is clearly in a state of extreme uncontrolled anxiety. Benzodiazepines are the drug of choice for acute episodes of anxiety because of their rapid onset of action.

Benzodiazepines do not have a very short half-life.

Benzodiazepines are associated with physical dependence.

Benzodiazepines do not cure generalized anxiety, nor do any other drugs.

 

DIF:    Cognitive Level: Analysis                  REF:    p. 384

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

  1. A nurse compares the actions of benzodiazepines with those of buspirone (BuSpar). Which statement is correct regarding buspirone (BuSpar)?
a. Buspirone is not a central nervous system depressant.
b. The effects of buspirone are more rapid than those of benzodiazepines.
c. Buspirone is suitable for an as-needed medication use.
d. The potential for abuse is higher with buspirone than with the benzodiazepines.

 

 

ANS:   A

Buspirone is not a central nervous system depressant.

The effects of buspirone manifest less rapidly than those of the benzodiazepines.

Buspirone is not suitable for an as-needed medication because of the delay in therapeutic effects.

The potential for abuse is lower with buspirone than with the benzodiazepines.

 

DIF:    Cognitive Level: Analysis                  REF:    p. 384

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

  1. A nurse provides education for a patient who has just started taking buspirone (BuSpar). The patient asks the nurse, “When should I expect to see an effect from the medication?” The nurse’s best response would be based on the understanding that the effects of buspirone begin in most patients during which time frame?
a. 3 days
b. 24 to 48 hours
c. 1 day
d. 4 to 6 weeks

 

 

ANS:   D

Although an initial response to buspirone may occur as early as 1 week, it may take up to 4 to 6 weeks for peak results of the medication to occur.

One to 3 days is too short an interval to expect the effects of buspirone to develop.

 

DIF:    Cognitive Level: Application             REF:    pp. 384-385

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

  1. A patient is being discharged from the hospital on buspirone (BuSpar). A nurse is providing education on the effects and side effects of the medication. What statement made by the patient would most concern the nurse?
a. “I will take the medication with grapefruit juice.”
b. “I will limit alcohol-containing products.”
c. “I can take the medication with food.”
d. “This drug is not addicting.”

 

 

ANS:   A

Grapefruit juice can increase levels of buspirone, which can cause drowsiness and dysphoria; this statement indicates a need for further teaching.

The patient is correct in stating that alcohol-related products should be limited.

The patient is correct that the medication may be taken with food.

The patient is correct in stating that buspirone is not addicting.

 

DIF:    Cognitive Level: Analysis                  REF:    p. 385

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

Additional information

Add Review

Your email address will not be published. Required fields are marked *